Source link : https://newshealth.biz/health-news/promising-results-for-sonelokimab-in-early-phase-axspa-trial/
Results of the phase 2, open-label, single-arm S-OLARIS study provide ‘proof of concept’ that the novel IL-17A/F-inhibiting nanobody has an effect on patients with axial spondyloarthritis. Medscape Medical News Source link : https://www.medscape.com/viewarticle/promising-results-novel-nanobody-sonelokimab-early-phase-2026a1000k7q?src=rss Author : Publish date : 2026-06-16 08:52:00 Copyright for syndicated content belongs to the linked Source.
The post Promising Results for Sonelokimab in Early-Phase axSpA Trial first appeared on News Health.
—-
Author : News Health
Publish date : 2026-06-16 08:52:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8